Prevalence of sarcopenia and associated factors in hospitalised older patients: A cross‐sectional study

Prevalence of sarcopenia and associated factors in hospitalised older patients: A... Policy Impact: Sarcopenia is highly prevalent in older inpatients. Polypharmacy seems to be related to sarcopenia, and this finding deserves further study.Practice Impact: The finding that sarcopenia is highly prevalent in older inpatients suggests that geriatricians should pay more attention to its identification, prevention and treatment. The assessment of polypharmacy is particularly important in older patients with sarcopenia.IntroductionSarcopenia is a geriatric syndrome that is characterised by age‐related loss of muscle mass, muscle strength and muscle function . Sarcopenia has been associated with many negative health outcomes among older adults, such as a decline in functional status, falls, poor quality of life and increased mortality . Therefore, sarcopenia is of increasing interest to geriatricians and researchers. Recently, sarcopenia was assigned the new ICD‐10‐CM (M62.84) code, and this has been considered to represent ‘a major step forward in recognising sarcopenia’ .The diagnostic criteria for sarcopenia are still widely debated . More than six major diagnostic criteria and screening tools for sarcopenia are currently available . Among them, diagnostic strategies for sarcopenia from the European Working Group on Sarcopenia in Older People (EWGSOP) and Foundation for the National Institutes of Health Sarcopenia project are the most widely used. For studies conducted in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Australasian Journal on Ageing Wiley

Prevalence of sarcopenia and associated factors in hospitalised older patients: A cross‐sectional study

Loading next page...
 
/lp/wiley/prevalence-of-sarcopenia-and-associated-factors-in-hospitalised-older-Ll5u7lTBj1
Publisher
Wiley
Copyright
Copyright © 2018 AJA Inc.
ISSN
1440-6381
eISSN
1741-6612
D.O.I.
10.1111/ajag.12492
Publisher site
See Article on Publisher Site

Abstract

Policy Impact: Sarcopenia is highly prevalent in older inpatients. Polypharmacy seems to be related to sarcopenia, and this finding deserves further study.Practice Impact: The finding that sarcopenia is highly prevalent in older inpatients suggests that geriatricians should pay more attention to its identification, prevention and treatment. The assessment of polypharmacy is particularly important in older patients with sarcopenia.IntroductionSarcopenia is a geriatric syndrome that is characterised by age‐related loss of muscle mass, muscle strength and muscle function . Sarcopenia has been associated with many negative health outcomes among older adults, such as a decline in functional status, falls, poor quality of life and increased mortality . Therefore, sarcopenia is of increasing interest to geriatricians and researchers. Recently, sarcopenia was assigned the new ICD‐10‐CM (M62.84) code, and this has been considered to represent ‘a major step forward in recognising sarcopenia’ .The diagnostic criteria for sarcopenia are still widely debated . More than six major diagnostic criteria and screening tools for sarcopenia are currently available . Among them, diagnostic strategies for sarcopenia from the European Working Group on Sarcopenia in Older People (EWGSOP) and Foundation for the National Institutes of Health Sarcopenia project are the most widely used. For studies conducted in

Journal

Australasian Journal on AgeingWiley

Published: Jan 1, 2018

Keywords: ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off